|
Volumn 48, Issue 1, 2001, Pages 83-87
|
Therapeutic activity of 7-[(2-trimethylsilyl)ethyl)]-20 (S)-camptothecin against central nervous system tumor-derived xenografts in athymic mice
a a a a a |
Author keywords
Camptothecin derivatives; Central nervous system malignancies; Human tumor xenografts; Karenitecin
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BUSULFAN;
CAMPTOTHECIN DERIVATIVE;
KARENITECIN;
PROCARBAZINE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CENTRAL NERVOUS SYSTEM TUMOR;
CONTROLLED STUDY;
DEATH;
DRUG ACTIVITY;
DRUG EFFICACY;
EPENDYMOMA;
FEMALE;
GLIOMA;
HUMAN;
HUMAN TISSUE;
MALE;
MEDULLOBLASTOMA;
MOUSE;
MULTIDRUG RESISTANCE;
NONHUMAN;
NUDE MOUSE;
PRIORITY JOURNAL;
STATISTICAL ANALYSIS;
SURVIVAL RATE;
TUMOR XENOGRAFT;
ANIMALS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
BRAIN NEOPLASMS;
CAMPTOTHECIN;
FEMALE;
HUMANS;
MALE;
MICE;
MICE, INBRED BALB C;
MICE, NUDE;
NEOPLASM TRANSPLANTATION;
TRANSPLANTATION, HETEROLOGOUS;
|
EID: 0034917320
PISSN: 03445704
EISSN: None
Source Type: Journal
DOI: 10.1007/s002800000274 Document Type: Article |
Times cited : (29)
|
References (16)
|